Stalevo, a combo product for Parkinson's disease
August 2003
See FDA information concerning a possible increased cardiovascular risk with Stalevo
Novartis is now marketing Stalevo, a combo product for Parkinson's disease.
It contains both standard-release carbidopa/levodopa (Sinemet, etc)...PLUS entacapone (Comtan).
It's for patients who already take these drugs separately... or for patients who have "wearing-off" on levodopa. Adding entacapone boosts efficacy of levodopa and helps it last longer.
Practical advice for a better career, with unlimited access to CE
Pharmacy Technician's Letter includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 120+ CE courses, including the popular CE-in-the-Letter
- Helpful, in-depth Technician Tutorials
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote